Johnson & Johnson buy fenjal
Start price
29.12.19
/
50%
€130.48
Target price
04.11.21
€150.00
Performance (%)
7.13%
End price
02.04.21
€139.78
Summary
This prediction ended on 02.04.21 with a price of €139.78. The BUY prediction by fenjal finished with a performance of 7.13%. fenjal has a follow-up prediction for Johnson & Johnson where he still thinks Johnson & Johnson is a Buy. Dividends of €3.48 are taken into consideration when calculating the performance. fenjal has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | -0.044% | -0.044% | -9.124% | 0.058% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by fenjal for this prediction
In the thread Johnson & Johnson diskutieren
Buy mit Kursziel 150,0